Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
増殖亢進性障害の治療
Document Type and Number:
Japanese Patent JP2004506691
Kind Code:
A
Abstract:
We describe methods and compositions for treating a patient suffering from a hyperproliferative disorder or photoageing. Our methods involve blocking the activity of a retinol binding protein receptor (RBPr) in cells of the patient, and/or administering to the patient an antagonist of a retinol binding protein receptor (RBPr) and/or lowering the endogenous level of retinoic acid (RA) in cells of said patient.

Inventors:
Ward, Simon
Bavik, Claes
Cork, Michael
Taj-Agnini, Reikid
Application Number:
JP2002520841A
Publication Date:
March 04, 2004
Filing Date:
August 17, 2001
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Molculer Skin Care Limited
International Classes:
A61K31/10; A61K31/11; A61K31/145; A61K31/285; A61K31/415; A61K31/56; A61K31/575; A61K31/7088; A61K31/7105; A61K31/711; A61K38/00; A61K38/17; A61K39/395; A61K45/00; A61K48/00; A61P1/16; A61P3/02; A61P3/06; A61P5/16; A61P9/00; A61P9/10; A61P15/08; A61P17/00; A61P17/02; A61P17/04; A61P17/06; A61P17/10; A61P17/12; A61P17/14; A61P17/16; A61P19/08; A61P19/10; A61P25/18; A61P25/24; A61P31/12; A61P31/18; A61P31/20; A61P31/22; A61P35/00; A61P37/06; A61P39/06; A61P43/00; C07D231/12; C07J53/00; G01N33/50; C07K16/28; C12Q1/02; C12Q1/32; G01N33/15; G01N33/566; (IPC1-7): A61K45/00; A61K31/11; A61K31/145; A61K31/285; A61K31/415; A61K31/56; A61K31/7088; A61K31/7105; A61K31/711; A61K38/00; A61K39/395; A61K48/00; A61P1/16; A61P3/02; A61P3/06; A61P5/16; A61P9/00; A61P9/10; A61P15/08; A61P17/02; A61P17/04; A61P17/06; A61P17/10; A61P17/12; A61P17/14; A61P17/16; A61P19/08; A61P19/10; A61P25/18; A61P25/24; A61P31/12; A61P31/18; A61P31/20; A61P31/22; A61P35/00; A61P37/06; A61P39/06; A61P43/00; C12Q1/02; C12Q1/32; G01N33/15; G01N33/50
Domestic Patent References:
JPS63258410A1988-10-25
Attorney, Agent or Firm:
Sumiko Shimosaka
Mitsuo Matsuda



 
Previous Patent: JP2004506690

Next Patent: アミノ酸鎮痙薬の新規用途